TOMM40-APOE haplotypes are associated with cognitive decline in non-demented Blacks.

TitleTOMM40-APOE haplotypes are associated with cognitive decline in non-demented Blacks.
Publication TypeJournal Article
Year of Publication2021
AuthorsDeters, KD, Mormino, EC, Yu, L, Lutz, MW, Bennett, DA, Barnes, LL
JournalAlzheimers Dement
Volume17
Issue8
Pagination1287-1296
Date Published2021 Aug
ISSN1552-5279
KeywordsAged, Alleles, Apolipoproteins E, Black or African American, Cognition, Cognitive Dysfunction, Female, Genotype, Haplotypes, Humans, Male, Membrane Transport Proteins, Memory, Episodic, Mitochondrial Precursor Protein Import Complex Proteins, Poly T
Abstract

INTRODUCTION: The goal was to investigate effects of APOE-TOMM40-'523 haplotypes on cognitive decline in non-demented non-Hispanic Blacks (NHB), and determine whether effects differ from non-Hispanic Whites (NHW).

METHODS: The impact of zero to two copies of the '523-Short variant (S; poly-T alleles < 20) within apolipoprotein E (APOE) genotype on a composite measure of global cognition and five domains was examined.

RESULTS: In NHB with ε3/ε3 (N = 294), '523-S/S was associated with faster decline in global cognition (β = -0.048, P = 0.017), episodic memory (β = -0.05, P = 0.031), and visuospatial ability (β = -0.037, P = 0.034) relative to those without '523-S. For NHB ε4+ (N = 182), '523-S/S had slower decline in global cognition (β = 0.047, P = 0.042) and visuospatial ability (β = 0.07, P = 0.0005) relative to '523-S non-carriers. NHB ε4+ with '523-S also had a slower rate of decline than NHWs ε4+ with '523-S.

DISCUSSION: '523-S/S has a different effect on cognitive decline among NHB dependent on APOE allele. Differences in the effect of ε4-'523-S in NHB may explain prior mixed findings on ε4 and decline in this population.

DOI10.1002/alz.12295
Alternate JournalAlzheimers Dement
PubMed ID33580752
PubMed Central IDPMC8855738
Grant ListP30 AG066515 / AG / NIA NIH HHS / United States
R01 AG017917 / AG / NIA NIH HHS / United States
P30 AG010161 / AG / NIA NIH HHS / United States
RF1 AG022018 / AG / NIA NIH HHS / United States
R01 AG022018 / AG / NIA NIH HHS / United States
K01 AG051718 / AG / NIA NIH HHS / United States
R01 AG015819 / AG / NIA NIH HHS / United States